Entera Bio Ltd. (ENTX)
2.92
-0.10
(-3.31%)
USD |
NASDAQ |
Oct 23, 16:00
2.905
-0.02
(-0.51%)
After-Hours: 20:00
Entera Bio Net Income (Quarterly) : -7.312M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.312M |
| March 31, 2026 | -3.505M |
| December 31, 2025 | -3.016M |
| September 30, 2025 | -3.20M |
| June 30, 2025 | -2.656M |
| March 31, 2025 | -2.567M |
| December 31, 2024 | -2.358M |
| September 30, 2024 | -3.021M |
| June 30, 2024 | -2.145M |
| March 31, 2024 | -2.017M |
| December 31, 2023 | -1.995M |
| September 30, 2023 | -2.379M |
| June 30, 2023 | -2.325M |
| March 31, 2023 | -2.19M |
| December 31, 2022 | -3.035M |
| September 30, 2022 | -3.067M |
| June 30, 2022 | -3.185M |
| March 31, 2022 | -3.784M |
| December 31, 2021 | 4.916M |
| Date | Value |
|---|---|
| September 30, 2021 | -3.214M |
| June 30, 2021 | -2.577M |
| March 31, 2021 | -2.296M |
| December 31, 2020 | -2.251M |
| September 30, 2020 | -1.624M |
| June 30, 2020 | -3.19M |
| March 31, 2020 | -2.918M |
| December 31, 2019 | -3.44M |
| September 30, 2019 | -2.994M |
| June 30, 2019 | -1.366M |
| March 31, 2019 | -2.995M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -3.775M |
| September 30, 2017 | -3.656M |
| June 30, 2017 | -2.259M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| BioLineRx Ltd. | -4.414M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 9.262M |
| Can-Fite BioPharma Ltd. | -- |
| Eocene Ltd. | -2.723M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 7.312M |
| EPS Diluted (Quarterly) | -0.1449 |
| Enterprise Value | 125.92M |
| Earnings Yield | -12.04% |
| Normalized Earnings Yield | -12.04 |